Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Pharma Industry News AstraZeneca Pharma India FY25 revenue jumps 32% to Rs 1,716cr on strong oncology growth AstraZeneca Pharma India reports ₹1,716 Cr in FY25 revenue with 32% growth. Explore stock impact, new drug launches, and what’s next for pharma investors. byPallavi MadhirajuJune 2, 2025